7
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Practice patterns for chronic hypoparathyroidism: data from patients and physicians in France

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Context

          Recent guidelines have provided recommendations for the care of patients with chronic hypoparathyroidism. Very little is known about actual physicians’ practices or their adherence to such guidelines.

          Objective

          To describe the physicians’ practice patterns and their compliance with international guidelines.

          Design

          The cohort studies included were Épi-Hypo (118 physicians and 107 patients, from September 2016 to December 2019) and ePatients (110 patients, November 2019).

          Methods

          Internet-based cohorts involving all settings at a nationwide level (France). Participants were (i) physicians treating patients with chronic hypoparathyroidism and patients with chronic hypoparathyroidism either participating in the (ii) Épi-Hypo study (Épi-Hypo 2019 patients), or (iii) Hypoparathyroidism France, the national representative association (ePatients).

          Results

          The physicians’ specialties were mainly endocrinology (61%), nephrology (28%), family medicine (2.5%), pediatrics (2.5%), rheumatology (2%), or miscellaneous (4%) and 45% were practicing in public universities. The median number of pharmaceutical drug classes prescribed was three per patient. The combination of active vitamin D and calcium salt was given to 59 and 58% of ePatients and Épi-Hypo 2019 patients, respectively. Eighty-five percent of ePatients and 87% of physicians reported monitoring plasma calcium concentrations at a steady state at least twice a year. In 32 and 26% of cases, respectively, ePatients and physicians reported being fully in accordance with international guidelines that recommend targeting symptoms, plasma calcium and phosphate values, and urine calcium excretion.

          Conclusions

          The care of patients with chronic hypoparathyroidism involves physicians with very different practices, so guidelines should include and target other specialists as well as endocrinologists. Full adherence to the guidelines is low in France.

          Related collections

          Most cited references30

          • Record: found
          • Abstract: found
          • Article: not found

          GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables.

          This article is the first of a series providing guidance for use of the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system of rating quality of evidence and grading strength of recommendations in systematic reviews, health technology assessments (HTAs), and clinical practice guidelines addressing alternative management options. The GRADE process begins with asking an explicit question, including specification of all important outcomes. After the evidence is collected and summarized, GRADE provides explicit criteria for rating the quality of evidence that include study design, risk of bias, imprecision, inconsistency, indirectness, and magnitude of effect. Recommendations are characterized as strong or weak (alternative terms conditional or discretionary) according to the quality of the supporting evidence and the balance between desirable and undesirable consequences of the alternative management options. GRADE suggests summarizing evidence in succinct, transparent, and informative summary of findings tables that show the quality of evidence and the magnitude of relative and absolute effects for each important outcome and/or as evidence profiles that provide, in addition, detailed information about the reason for the quality of evidence rating. Subsequent articles in this series will address GRADE's approach to formulating questions, assessing quality of evidence, and developing recommendations. Copyright © 2011 Elsevier Inc. All rights reserved.
            • Record: found
            • Abstract: found
            • Article: not found

            From best evidence to best practice: effective implementation of change in patients' care

            The Lancet, 362(9391), 1225-1230
              • Record: found
              • Abstract: found
              • Article: not found

              Effectiveness and efficiency of guideline dissemination and implementation strategies

              To undertake a systematic review of the effectiveness and costs of different guideline development, dissemination and implementation strategies. To estimate the resource implications of these strategies. To develop a framework for deciding when it is efficient to develop and introduce clinical guidelines.

                Author and article information

                Journal
                Endocr Connect
                Endocr Connect
                EC
                Endocrine Connections
                Bioscientifica Ltd (Bristol )
                2049-3614
                23 December 2021
                01 January 2022
                : 11
                : 1
                : e210350
                Affiliations
                [1 ]Assistance Publique-Hôpitaux de Paris, Hôpital Européen Georges Pompidou, Service de Physiologie, Paris , France
                [2 ]Centre de Référence des Maladies Rares du Calcium et du Phosphore Filière de Santé Maladies Rares OSCAR , Paris, France
                [3 ]Centre de Recherche des Cordeliers , INSERM, Sorbonne Université, Université de Paris, INSERM, UMRS1138, Paris, France
                [4 ]Hypoparathyroïdisme France , Annecy, France
                [5 ]Department of Endocrinology , Assistance Publique-Hôpitaux de Paris, Hôpital Cochin, Université de Paris, Paris, France
                [6 ]Université Paris-Saclay , Inserm U1185, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Hôpital Bicêtre, Service d’Endocrinologie et des Maladies de la Reproduction, Centre de Référence des Maladies Rares du Métabolisme du Calcium et du Phosphate, Le Kremlin-Bicêtre, France
                [7 ]Université Paris-Dauphine , PSL Research University, CNRS, UMR 7088, DRM [Ermes], Paris, France
                [8 ]CHU Dupuytren , Hôpital Mère Enfant, Endocrinologie Pédiatrique, Limoges, France
                [9 ]Université Paris-Saclay , Inserm U1185, Physiologie et Physiopathologie Endocriniennes, Assistance Publique-Hôpitaux de Paris, Service d’Endocrinologie et Diabète de l’Enfant, Centre de Référence des Maladies Rares du Calcium et du Phosphore et Filière de Santé Maladies Rares OSCAR, Hôpital Bicêtre Paris Saclay, Le Kremlin-Bicêtre, France
                [10 ]Assistance Publique-Hôpitaux de Paris , Institut Necker-Enfants Malades, INSERM U1151 – CNRS UMR 8253, Paris, France
                [11 ]Chirurgie Cancérologique , Digestive et Endocrine, Institut des Maladies de l’Appareil Digestif, Hôtel Dieu, CHU Nantes, France
                [12 ]Association Francophone de Chirurgie Endocrinienne (AFCE) , France
                [13 ]Université de Lille , CHU Lille, Institut Pasteur Lille, Inserm U1190, Lille, France
                [14 ]Molecular & Cellular Biology Graduate Program , Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas, USA
                [15 ]Assistance Publique-Hôpitaux de Paris , Hôpital Cochin, Biochimie et Génétique Moléculaires, Paris, France
                [16 ]INSERM , U1169, Université Paris Sud, Hôpital Bicêtre, Le Kremlin Bicêtre, France
                [17 ]Assistance Publique-Hôpitaux de Paris , Hôpital Européen Georges Pompidou, Unité de Recherche Clinique, Paris, France
                [18 ]INSERM , U1418, CIC-EC, Hôpital Européen Georges Pompidou, Paris, France
                [19 ]Service Endocrinologie Diabète et Nutrition , CHU de Bordeaux, Université de Bordeaux, Pessac, France
                [20 ]CHU Lille , Department of Endocrinology, Diabetology and Metabolism, Inserm U1190, EGID, Lille, France
                [21 ]CNRS , ERL8228, Paris, France
                Author notes
                Correspondence should be addressed to J-P Bertocchio or P Houillier: jpbertocchio@ 123456gmail.com or pascal.houillier@ 123456inserm.fr
                Article
                EC-21-0350
                10.1530/EC-21-0350
                8859964
                34939939
                c29b1ead-d5b2-4e46-95e3-b2a0b7314658
                © The authors

                This work is licensed under a Creative Commons Attribution 4.0 International License.

                History
                : 03 December 2021
                : 23 December 2021
                Categories
                Research

                hypoparathyroidism,practice patterns,physicians,epidemiological studies,hypocalcemia

                Comments

                Comment on this article

                Related Documents Log